… , relapsing depression necessitates continuing pharmacotherapy, an alternative dosing …
involves three stages: (1) short-term, which continues until symptoms remit; (2) continuation, …

… end of the continuation phase (6 months after randomization) were 35.2% for the fluoxetine
group and … studied as a pharmacotherapeutic intervention in order to prevent MDD relapse is …

… , and continuation phase pharmacotherapy has become the … courses of maintenance
pharmacotherapy are recommended for … of longer-term pharmacotherapy, treatment utilization …

… treatment, 42 did not meet the remission criteria until late in the acute phase and … continuation
phase of the study with a Hamilton depression score of 7 or less at the final acute phase …

… A total of 134 patients at the end of the open phase met criteria for remission and were …
28-week continuation phase. For the continuation phase, all patients had their fluoxetine dose of …

… the continuation phase, and 145 finished the continuation phase and experienced a recovery
of the current depressive episode (57.3%). A total of 140 of these 145 patients met entry …

… of moclobemide or fluoxetine therapy agreed to continue and … of continuation therapy with
moclobemide or fluoxetine.65 No … ) in the fluoxetine group, but 23% of patients in the fluoxetine …

… treatment with initial daily dosages of either 50 mg of sertraline or 20 mg of fluoxetine. In the
… acute phase as well as during the continuation phase. Both sertraline and fluoxetine were …

… in placebo-controlled continuation phase therapy studies of … of C-CT or active pharmacotherapy
(fluoxetine; FLX) plus clinical … ) the efficacy of continuation phase pharmacotherapy (FLX) …

… However, findings from studies comparing fluoxetine with other antidepressants are
controversial. In this systematic review, the efficacy and tolerability of fluoxetine was compared with …